Next Article in Journal
Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression
Next Article in Special Issue
Three-Dimensional In Vitro Hydro- and Cryogel-Based Cell-Culture Models for the Study of Breast-Cancer Metastasis to Bone
Previous Article in Journal
Nano-Pulse Stimulation for the Treatment of Pancreatic Cancer and the Changes in Immune Profile
Previous Article in Special Issue
Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation

The Osteoclast in Bone Metastasis: Player and Target

Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100 L’Aquila, Italy
Author to whom correspondence should be addressed.
Cancers 2018, 10(7), 218;
Received: 1 June 2018 / Revised: 21 June 2018 / Accepted: 21 June 2018 / Published: 27 June 2018
(This article belongs to the Special Issue Targeting Bone Metastasis in Cancer)
Bone metastases are frequently the final fate of breast and prostate cancer patients. According to the definition of metastasis as an incurable disease, to date there are no effective treatments for tumor-associated bone metastases and this represents a real challenge for the researchers in the field. The bone is a heterogeneous environment that represents a fertile soil for tumor cells, supporting their growth. Among the different cell types present in the bone, in this review we will focus our attention on the osteoclasts, which are crucial players in the so called “vicious cycle”, a phenomenon triggered by tumor cells eventually leading to both tumor proliferation as well as bone deregulation, thus fueling the development of bone metastasis. The complex network, linking tumor cells to the bone by activating osteoclasts, represents a fruitful target for the treatment of bone metastases. In this review we will describe how tumor cells perturb the bone microenvironment by actively influencing osteoclast formation and activity. Moreover, we will describe the current antiresorptive drugs employed in the treatment of bone metastases as well as new, targeted therapies able to affect both cancer cells and osteoclasts. View Full-Text
Keywords: breast cancer; bone metastases; osteoclasts; antiresorptive drugs; vicious cycle breast cancer; bone metastases; osteoclasts; antiresorptive drugs; vicious cycle
Show Figures

Figure 1

MDPI and ACS Style

Maurizi, A.; Rucci, N. The Osteoclast in Bone Metastasis: Player and Target. Cancers 2018, 10, 218.

AMA Style

Maurizi A, Rucci N. The Osteoclast in Bone Metastasis: Player and Target. Cancers. 2018; 10(7):218.

Chicago/Turabian Style

Maurizi, Antonio, and Nadia Rucci. 2018. "The Osteoclast in Bone Metastasis: Player and Target" Cancers 10, no. 7: 218.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop